Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions
Acute Ischemic StrokeReperfusionLarge Vessel Occlusion
Interventions
DRUG

Y-6 sublingual tablets

Take Y-6 sublingual tablets for 28 days continuously.

DRUG

Placebo tablets of Y-6 sublingual tablet

Take Placebo tablets of Y-6 sublingual tablet for 28 days continuously.

Trial Locations (3)

Unknown

RECRUITING

Liuzhou Workers' Hospital, Liuzhou

RECRUITING

Hunan Provincial People's Hospital, Changsha

RECRUITING

Pingxiang people's hospital, Pingxiang

Sponsors
All Listed Sponsors
collaborator

Neurodawn Pharmaceutical Co., Ltd.

INDUSTRY

lead

Beijing Tiantan Hospital

OTHER